ebola virus infect caps deadly hemorrhage disease vaccine therapeutic receive regulatory approve show iso three q neutral monoclonal antibody mab surface glycoprotein gp identify west africa sequence immune china these macaque antigenspecif single b cell sort demons potent active pseudo live indeed complement bochum partial em mutagenesi analysis suggest recon novel editor head target glycol cap subunit appear influence bind receptor npc treatment provide partial signifies protect mouse model infect could serv promise candid prophylact therapeutic intervene 